Clinical Trial Update: Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating intravenous thrombolysis with rhTNK-tPA for acute ischemic stroke due to non-large vessel occlusion in an extended time…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• rhTNK-tPA (tenecteplase)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Acute Ischemic Stroke | Phase 4 | Status: COMPLETED